Recursion prices $200 million stock offering at $3.25 a share
RXRX•Recursion Pharmaceuticals priced an underwritten offering of 61.54 million Class A shares at $3.25 each, for expected gross proceeds of approximately $200 million before expenses. The offering is expected to close on or about October 16, 2026.
1. Offering details
Recursion Pharmaceuticals priced an underwritten offering of 61,540,000 shares of Class A common stock at $3.25 per share. The company expects gross proceeds of approximately $200 million before underwriting discounts, commissions and offering expenses; all shares will be sold by Recursion. Closing is expected on or about October 16, 2026, subject to customary conditions.
